once daily logiparin vs twice daily logiparin | No demonstrated result | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
---|
Recurrent thromboembolic event | 1.00 [0.02 55.80] | p=1.00 | 0 | 20 | 1 | Siegbahn, | All cause death | 1.00 [0.02 55.80] | p=1.00 | 0 | 20 | 1 | Siegbahn, | Bleeding | 1.00 [0.02 55.80] | p=1.00 | 0 | 20 | 1 | Siegbahn, | TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |